Kansas City, Mo. — It started with a half-day event covering national threats to biosecurity and ended with an investment forum that brought
together companies and venture capitalists. And it was all punctuated by a Homecoming event, in conjunction with CVC in Kansas
City, that reeled in close to 750 people representing 130 animal-health organizations and companies.
All of these initiatives are designed to spur innovation and investment in animal health, says the new chair of the KC Animal
Health Corridor George Heidgerken, who recently spoke with DVM Newsmagazine at CVC in Kansas City.
That's what it is all about, Heidgerken adds, creating a fertile ground to help animal-health companies make discoveries,
bring them to market and train the next generation of veterinarians and animal-health employees. The KC Animal Health Corridor
is attempting to bridge all stakeholders in animal health from companies to veterinary schools to government to investment
capitalists.
Heidgerken, who also serves as president and CEO of Boehringer Ingelheim Vetmedica, says that he is amazed at how far the
corridor has come in just five years.
"It's also nice to have the corridor recognized by the government." Heidgerken is referring to a resolution passing the U.S.
House of Representatives last year recognizing the Animal Health Corridor as "the national center of the animal-health industry."
The activities, however, spread far beyond the region from Manhattan, Kansas to Columbia, Missouri into metropolitan Kansas
City. These collaborations all lay a foundation in areas of disease research and investment of novel new animal-health products.
The plan is to plant seeds of succession to maintain a highly skilled animal-health workforce for the future.
Highlights this year include the start of construction of the Department of Homeland Security's National Bio and Agro-Defense
Facility (NBAF). (See the story on the next page.) Another activity was the second Animal Health Investment Forum that brought
together scientists, companies and investment capitalists for presentations. The Kansas Bioscience Authority is considering
the feasability of creating an innovation center to investigate animal-health problems that one single company or institution
couldn't do alone. Examples, Heidgerken says, might be to further study antibiotic resistance or impacts of zoonotic diseases.
"Some of these bigger issues really can be tackled in an institute that has funding and cooperation with industry," he says.
"We have the clear understanding that education and workforce is the power that will sustain our businesses in the area. If
we have a rich workforce, great schools, great cooperation in academic institutions and federal institutions like NBAF, then
we are going to have a strong workforce. The progress we have made over the last five years has been very enriching," Heidgerken
adds.